Reckitt is indeed after Merck’s consumer unit, and it’s ready for a close race

Carly Helfand

As Reuters reported this weekend, and Germany's Bayer have emerged as front-runners for the , which could go for $ 13.5 billion–or higher, if a bidding war ensues.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS